RISK OF COGNITIVE IMPAIRMENT AND DEMENTIA IN TOTAL JOINT ARTHROPLASTY
RISK OF COGNITIVE IMPAIRMENT AND DEMENTIA IN TOTAL JOINT ARTHROPLASTY
批准号:
10743158
负责人:
Hilal Maradit Kremers
金额:
$33.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-03-01 至 2024-11-30
关键词:
AddressAgeAgingAlzheimer&aposs DiseaseAmericanAmyloid beta-ProteinAutopsyBrainCase StudyCeramicsCharacteristicsChromiumChronicClassificationClinicClinicalCobaltCognitionCognitiveCorrosionDataDementiaEducationEligibility DeterminationEpidemicEpidemiologyExposure toFormalinFreezingFundingFutureGenotypeGoalsHip JointHip ProsthesisImmune responseImpaired cognitionImplantIndividualInfrastructureIonsKidney DiseasesKnee ProsthesisKnee jointKnowledgeLaboratoriesLong-Term EffectsMeasuresMedical Record LinkageMetalsMethodsMonitorMorbidity - disease rateNegative FindingNerve DegenerationNeurocognitiveNeurocognitive DeficitObesityOperative Surgical ProceduresParaffin EmbeddingPatient riskPatientsPoliciesPolyethylenesPopulation StudyProceduresPublic HealthPublishingQuality of lifeRecordsRegistriesReplacement ArthroplastyResearchRiskRisk FactorsRoleSafetySeriesSerumStructureSurfaceSynovial FluidSystemTimeTissue EmbeddingTissuesTitaniumUnited Statesbrain tissuecerebrovascular pathologyclinical riskcognitive functioncognitive testingcohortcostdata registrydata resourcedementia riskexperiencehigh riskimproved mobilitymortalityneuroimagingneuroimaging markerneuropathologyneurotoxicitypopulation basedprocedure safetyprospectivepublic health relevancerecruitsexvascular risk factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Total joint arthroplasty (TJA) is the fastest growing elective surgery in the nation. Over 7 million
Americans are currently living artificial hip or knee joints and this is expected to reach epidemic
proportions as a result of growing demand for improved mobility and quality of life. Although TJA is a
safe and effective procedure, there is growing concern about the long-term safety of chronic exposure
to TJA implants. Indeed, in a growing number of published case reports, TJA is associated with
neurocognitive deficits several years after surgery. Yet, the long-term effects implant debris on brain
structure and cognitive function are unknown.
Large scale, population-based studies are needed to assess the potential contribution of chronic
exposure to TJA implant debris and subtypes (cobalt/chromium, polyethylene) to the risk of cognitive
decline and dementia. We propose to leverage the unique data resources of the Rochester
Epidemiology Project (REP, R01-AG034676), the Mayo Clinic Study of Aging (MCSA, U01-AG006786)
and the Mayo Alzheimer’s Disease Research Center (ADRC; P50 AG016574) as well as the Mayo
Clinic TJA registry to elucidate the long-term risk of dementia and cognitive impairment in TJA patients.
Using 5-decades of historical data from the REP, we will compare the risk of dementia and subtypes in
population-based cohorts of TJA patients and matched non-TJA subjects adjustingfor well-known
confounders (age, sex, obesity). We will further examine the risk according to implant types. Using
cross-sectional and longitudinal cognition and neuroimaging measures collected as part of the MCSA
cohort, we will determine whether cognitive status and neuroimaging markers of cognitive function are
worse in TJA patients compared with non-TJA subjects. Finally, we will correlate metal ion levels with
The reason for
the admin supplement is the following: We recognized the need to use more sensitive methods for
measuring metal levels on tissues. Therefore, instead of formalin-fixed paraffin-embedded tissues, we
will use frozen brain tissues. In year 4, we incurred substantial additional costs and developed and
validated new laboratory methods to measure metal levels in brain tissue at ‘ultra-trace’ levels.
cognitive function and structural changes on neuroimaging and postmortem tissues.
Successful completion of the proposed series of studies will be a key step towards understanding
whether chronic exposure to TJA implants is associated with cognitive impairment. Potential
downstream effects are significant including eligibility criteria for TJA, and monitoring high risk TJA
implants and patients who are most likely to suffer from systemiceffects. Even negative findings can
exert a significant public health impact by providing reassurance about the safety of TJA to millions of
current and future TJA patients.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3233/jad-221182
发表时间:
2023
期刊:
JOURNAL OF ALZHEIMERS DISEASE
影响因子:
4
作者:
[Beba, Alican, Peterson, Stephanie M., Brennan, Peter C., O'Byrne, Jamie, Machulda, Mary M., Jannetto, Paul I., Vemuri, Prashanthi, Lewallen, David G., Kremers, Hilal Maradit, Vassilaki, Maria]
通讯作者:
Vassilaki, Maria
RISK OF COGNITIVE IMPAIRMENT AND DEMENTIA IN TOTAL JOINT ARTHROPLASTY
-
批准号:10318585
-
项目类别:
-
资助金额:$65.52万
-
财政年份:2019
-
负责人:Hilal Maradit Kremers
-
依托单位:
Cardiotoxicity in Total Joint Arthroplasty
-
批准号:10453454
-
项目类别:
-
资助金额:$70.09万
-
财政年份:2019
-
负责人:Hilal Maradit Kremers
-
依托单位:
Methodology Core
-
批准号:10477005
-
项目类别:
-
资助金额:$35.92万
-
财政年份:2019
-
负责人:Hilal Maradit Kremers
-
依托单位:
RISK OF COGNITIVE IMPAIRMENT AND DEMENTIA IN TOTAL JOINT ARTHROPLASTY
-
批准号:10064124
-
项目类别:
-
资助金额:$65.52万
-
财政年份:2019
-
负责人:Hilal Maradit Kremers
-
依托单位:
Methodology Core
-
批准号:10703442
-
项目类别:
-
资助金额:$49.69万
-
财政年份:2019
-
负责人:Hilal Maradit Kremers
-
依托单位:
RISK OF COGNITIVE IMPAIRMENT AND DEMENTIA IN TOTAL JOINT ARTHROPLASTY
-
批准号:10532748
-
项目类别:
-
资助金额:$65.52万
-
财政年份:2019
-
负责人:Hilal Maradit Kremers
-
依托单位:
Cardiotoxicity in Total Joint Arthroplasty
-
批准号:10204100
-
项目类别:
-
资助金额:$70.09万
-
财政年份:2019
-
负责人:Hilal Maradit Kremers
-
依托单位:
Cardiotoxicity in Total Joint Arthroplasty
-
批准号:9980492
-
项目类别:
-
资助金额:$70.09万
-
财政年份:2019
-
负责人:Hilal Maradit Kremers
-
依托单位:
Methodology Core
-
批准号:10019360
-
项目类别:
-
资助金额:$35.92万
-
财政年份:2019
-
负责人:Hilal Maradit Kremers
-
依托单位:
Enhance Arthroplasty Research through Electronic Health Records and Nlp-Enabled Informatics
-
批准号:10358647
-
项目类别:
-
资助金额:$56.35万
-
财政年份:2018
-
负责人:Hilal Maradit Kremers
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: